The DOI matches its Crossref record; 41 of the 43 references it cites were found in a registry or an index.
Stimulatory effect of antidepressants on the production of IL-6
Abstract
A body of evidence indicates that the therapeutic activity of antidepressants is connected with their modulatory effect on the inflammatory response system and cell-mediated immunity. The present study was carried out to examine the effects of antidepressant agents, such as imipramne, venlafaxine, l-5-hydroxytryptophan, fluoxetine and a combination of l-5-hydroxytryptophan and fluoxetine, on the production of the pleotrophic cytokines TNF-alpha and IL-6. Diluted whole blood from fluoxetine-treated patients with treatment-resistant depression (TRD) (mean age: 50.6+/-3.9 years), age-matched healthy controls (mean age: 51.6+/-1.7 years) and younger healthy volunteers (mean age: 35.4+/-1.7 years) was stimulated with phytohemagglutinin (PHA) and lipopolysaccharide (LPS) for 48 h with or without incubation with the antidepressants at 10(-6) and 10(-5) M. The major findings of this study are: (1). imipramine and venlafaxine (at the higher concentration), 5-HTP (at lower and higher concentrations) and a combination of 5-HTP and fluoxetine (both at the lower concentration) increased the production of IL-6; (2). all drugs used did not affect TNF-alpha production. IL-6 production was significantly higher in depressed patients than in age-matched volunteers, whereas TNF-alpha production was significantly higher in older volunteers than in younger ones. We speculate that the therapeutic activity of these antidepressants is at least partly connected with their effect on the cytokine network and IL-6 production.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although some studies have demonstrated that antidepressants decrease inflammatory cytokines (38, 39), others report either no effect (31, 40, 41) or even increased levels (42, 43).”
From Individual differences in the peripheral immune system promote resilience versus susceptibility to social stress (2014) · cites this paper as [42]
In the citing paper
“Indeed, the literature describing the effects of standard antidepressants on systemic inflammation is highly mixed.”
From Individual differences in the peripheral immune system promote resilience versus susceptibility to social stress (2014) · cites this paper as [42]
Citations
Cites
Baumann, H., & Gauldie, J. (1994) · Immunology Today · doi:10.1016/0167-5699(94)90137-6 · Cited by 2,907
Interleukin-6 in Biology and Medicine
Akira, S., Taga, T., & Kishimoto, T. (1993) · Advances in immunology · doi:10.1016/s0065-2776(08)60532-5 · Cited by 1,402
Exercise and IL‐6 infusion inhibit endotoxin‐induced TNF‐α production in humans
Starkie, R., Ostrowski, S. R., Jauffred, S., Febbraio, M., & Pedersen, B. K. (2003) · The FASEB Journal · doi:10.1096/fj.02-0670fje · Cited by 790
Aging and proinflammatory cytokines
Bruunsgaard, H., Pedersen, M., & Pedersen, B. K. (2001) · Current Opinion in Hematology · doi:10.1097/00062752-200105000-00001 · Cited by 690
Maes, M., Meltzer, H. Y., Bosmans, E., Bergmans, R., Vandoolaeghe, E., Ranjan, R., & Desnyder, R. (1995) · Journal of Affective Disorders · doi:10.1016/0165-0327(95)00028-l · Cited by 622
Self-citationEndotoxin produces a depressive-like episode in rats
Yirmiya, R. (1996) · Brain Research · doi:10.1016/0006-8993(95)01415-2 · Cited by 604
Aderka, D., Le, J., & Vilček, J. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.143.11.3517 · Cited by 577
Corticotropin-Releasing Activity of Monokines
Woloski, B. M. R. N. J., Smith, E. M., Meyer, W. J., Fuller, G. M., & Blalock, J. E. (1985) · Science · doi:10.1126/science.2997929 · Cited by 486
Groote, D. D., Zangerle, P. F., Gevaert, Y., Fassotte, M., Beguin, Y. P., Pirenne, F., Pirenne, J., Gathy, R., Lopez, M., Dehart, I., et al. (1992) · Cytokine · doi:10.1016/1043-4666(92)90062-v · Cited by 470
The stress response and the hypothalamic-pituitary-adrenal axis: from molecule to melancholia
O’Connor, T. M. (2000) · QJM · doi:10.1093/qjmed/93.6.323 · Cited by 398
Research works printed but not linked: 2
- Służewska, 1996, Increased levels of alpha-1-acid glycoprotein and interleukin-6 in refractory depression, Depression, 39, 149
- Kubera M, Maes M, Kim Y-K, Lasoń W. Effect of serotonin and serotonergic agonists and antagonists on the production of TNF-α and IL-6 in human whole blood. Psychiatry Res [in press].
Cited by
Sorted by citations
A Meta-Analysis of Cytokines in Major Depression
Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E. K., & Lanctôt, K. L. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.033 · Cited by 4,729
Leonard, B., & Maes, M. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2011.12.005 · Cited by 805
Self-citationHodes, G. E., Pfau, M. L., Leboeuf, M., Golden, S. A., Christoffel, D. J., Bregman, D., Rebusi, N., Heshmati, M., Aleyasin, H., Warren, B. L., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1415191111 · Cited by 692
Neuroimmune mechanisms of depression
Hodes, G. E., Kana, V., Menard, C., Merad, M., & Russo, S. J. (2015) · Nature Neuroscience · doi:10.1038/nn.4113 · Cited by 585
Maes, M. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.06.014 · Cited by 544
Self-citationImmune and neuroendocrine mechanisms of stress vulnerability and resilience
Ménard, C., Pfau, M. L., Hodes, G. E., & Russo, S. J. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.90 · Cited by 374
Interleukin-6, a mental cytokine
Spooren, A., Kolmus, K., Laureys, G., Clinckers, R., De Keyser, J., Haegeman, G., & Gerlo, S. (2011) · Brain Research Reviews · doi:10.1016/j.brainresrev.2011.01.002 · Cited by 352
Pro-inflammatory cytokines and treatment response to escitaloprsam in major depressive disorder
Eller, T., Vasar, V., Shlik, J., & Maron, E. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.09.015 · Cited by 290
Integrating Interleukin-6 into depression diagnosis and treatment
Hodes, G. E., Ménard, C., & Russo, S. J. (2016) · Neurobiology of Stress · doi:10.1016/j.ynstr.2016.03.003 · Cited by 271
A psychoneuroimmunological review on cytokines involved in antidepressant treatment response
Janssen, D. G. A., Caniato, R. N., Verster, J. C., & Baune, B. T. (2010) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.1103 · Cited by 240
Inflammation-Associated Co-morbidity Between Depression and Cardiovascular Disease
Halaris, A. (2016) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2016_28 · Cited by 233
Cytokines and serotonin transporter in patients with major depression
Tsao, C.-W., Lin, Y.-S., Chen, C.-C., Bai, C., & Wu, S.-R. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.01.029 · Cited by 215
Cizza, G., Marques, A. H., Eskandari, F., Christie, I. C., Torvik, S., Silverman, M. N., Phillips, T. M., & Sternberg, E. M. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.05.035 · Cited by 208
Antidepressants inhibit interferon-γ-induced microglial production of IL-6 and nitric oxide
Hashioka, S., Klegeris, A., Monji, A., Kato, T., Sawada, M., McGeer, P. L., & Kanba, S. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.03.022 · Cited by 198
Wang, L., Wang, R., Liu, L., Qiao, D., Baldwin, D. S., & Hou, R. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.02.021 · Cited by 192
Baumeister, D., Ciufolini, S., & Mondelli, V. (2016) · Psychopharmacology · doi:10.1007/s00213-015-4044-5 · Cited by 183
Hope, S., Dieset, I., Agartz, I., Steen, N. E., Ueland, T., Melle, I., Aukrust, P., & Andreassen, O. A. (2011) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2011.08.003 · Cited by 164
Chronic fatigue syndrome and circulating cytokines: A systematic review
Blundell, S., Ray, K. K., Buckland, M., & White, P. D. (2015) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.07.004 · Cited by 159
Neurobiology of resilience in depression: immune and vascular insights from human and animal studies
Dudek, K., Dion‐Albert, L., Kaufmann, F. N., Tuck, E., Lebel, M., & Ménard, C. (2019) · European Journal of Neuroscience · doi:10.1111/ejn.14547 · Cited by 168
Targeting classical IL-6 signalling or IL-6 trans-signalling in depression?
Maes, M., Anderson, G., Kubera, M., & Berk, M. (2014) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2014.888417 · Cited by 140
Self-citationInflammation, Heart Disease, and Depression
Halaris, A. E. (2013) · Current Psychiatry Reports · doi:10.1007/s11920-013-0400-5 · Cited by 138
Pro-inflammatory biomakers in depression: Treatment with venlafaxine
Piletz, J. E., Halaris, A. E., Iqbal, O., Hoppensteadt, D., Fareed, J., Zhu, H., Sinacore, J. M., & DeVane, C. L. (2008) · The World Journal of Biological Psychiatry · doi:10.3109/15622970802573246 · Cited by 139
Gałecki, P., Szemraj, J., Bieńkiewicz, M., Zboralski, K., & Gałecka, E. (2009) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.1014 · Cited by 124
Diamond, M., Kelly, J. P., & Connor, T. J. (2006) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2005.11.011 · Cited by 123
Marcon, M., Herrmann, A. P., Mocelin, R., Rambo, C. L., Koakoski, G., de Abreu, M. S., Conterato, G. M. M., Kist, L. W., Bogo, M. R., Zanatta, L. C. B., et al. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4408-5 · Cited by 124
Martino, M., Rocchi, G., Escelsior, A., & Fornaro, M. (2012) · Current Neuropharmacology · doi:10.2174/157015912800604542 · Cited by 111
Cytokine profiles in women with different subtypes of major depressive disorder
Marques-Deak, A., NETO, F., Dominguez, W. V., Solis, A. C. D. O., Kurcgant, D., Sato, F. P., Ross, J. M., & Prado, E. D. F. G. B. (2005) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2005.11.003 · Cited by 111
Euteneuer, F., Dannehl, K., del Rey, A., Engler, H., Schedlowski, M., & Rief, W. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.76 · Cited by 107
A neuroimmunological perspective on anxiety disorders
Hou, R. H., & Baldwin, D. S. (2011) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.1259 · Cited by 113
Obuchowicz, E., Kowalski, J., Labuzek, K., Krysiak, R., Pendzich, J., & Herman, Z. S. (2005) · The International Journal of Neuropsychopharmacology · doi:10.1017/s146114570500547x · Cited by 115
Ubhi, K. K., Inglis, C. A., Mante, M., Patrick, C., Adame, A., Spencer, B. J., Rockenstein, E. M., May, V. E. L., Winkler, J., & Masliah, E. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.01.008 · Cited by 87
The role of macrophages in anti-inflammatory activity of antidepressant drugs
Nazimek, K., Strobel, S. D., Bryniarski, P., Kozlowski, M., Filipczak-Bryniarska, I., & Bryniarski, K. (2016) · Immunobiology · doi:10.1016/j.imbio.2016.07.001 · Cited by 91
Berardis, D. D., Conti, C. M., Serroni, N., Moschetta, F. S., Olivieri, L., Carano, A., Salerno, R. M., Cavuto, M., Farina, B., Alessandrini, M., et al. (2010) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463201002300204 · Cited by 80
Debnath, M., Berk, M., & Maes, M. H. J. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2021.110343 · Cited by 77
Self-citationGrundmann, O., Lv, Y., Kelber, O., & Butterweck, V. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.12.014 · Cited by 68
The negative immunoregulatory effects of fluoxetine in relation to the cAMP-dependent PKA pathway
Maes, M. H. J., Kenis, G., Kubera, M., de Baets, M., Steinbusch, H. W. M., & Bosmans, E. (2004) · International Immunopharmacology · doi:10.1016/j.intimp.2004.11.008 · Cited by 64
Self-citationFornaro, M., Rocchi, G., Escelsior, A., Contini, P., & Martino, M. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.08.007 · Cited by 59
Mukherjee, S., Mukherjee, B., Mukhopadhyay, R., Naskar, K., Sundar, S., Dujardin, J., Das, A. K., & Roy, S. (2012) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0001987 · Cited by 57
Novel investigational drugs targeting IL-6 signaling for the treatment of depression
Fonseka, T. M., McIntyre, R. S., Soczynska, J. K., & Kennedy, S. H. (2015) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2014.998334 · Cited by 56
Brás, J. P., de Suduiraut, I. G., Zanoletti, O., Monari, S., Meijer, M., Grosse, J., Barbosa, M. A., Santos, S. G., Sandi, C., & Almeida, M. I. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.10.018 · Cited by 58
Co-Morbidity between Cardiovascular Pathology and Depression: Role of Inflammation
Halaris, A. E. (2013) · Modern trends in psychiatry · doi:10.1159/000343981 · Cited by 53
The Role of C-Reactive Protein in Mood Disorders
Berardis, D. D., Campanella, D., Gambi, F., Rovere, R. L., Carano, A., Conti, C. M., Silvestrini, C., Serroni, N., Piersanti, D., Giuseppe, B. D., et al. (2006) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463200601900402 · Cited by 52
Antidepressants: Influence on cancer and immunity?
Frick, L. R., & Rapanelli, M. (2013) · Life Sciences · doi:10.1016/j.lfs.2013.01.020 · Cited by 47
Antidepressant Effects on Insulin Sensitivity and Proinflammatory Cytokines in the Depressed Males
Chen, Y.-C., Lin, W., Chen, Y.-J., Mao, W.-C., & Hung, Y.-J. (2010) · Mediators of Inflammation · doi:10.1155/2010/573594 · Cited by 46
Gazal, M., Souza, L. D., Fucolo, B. A., Wiener, C. D., Silva, R. A., Pinheiro, R. T., Jansen, K., Ghislene, G., Oses, J. P., & Kaster, M. P. (2013) · Psychiatry Research · doi:10.1016/j.psychres.2013.03.002 · Cited by 47
Fornaro, M., Martino, M., Battaglia, F., Colicchio, & Perugi, G. (2011) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s16382 · Cited by 46
Modulation of neuroimmune cytokine networks by antidepressants: implications in mood regulation
Nava, R. G., Adri, A. S., Filgueiras, I. S., Nóbile, A. L., Barcelos, P. M., Corrêa, Y. L. G., de Oliveira, S. F., Cabral‐Miranda, G., Dias, H. D., Schimke, L. F., et al. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03532-y · Cited by 53
Nichols, C. D. (2009) · Cardiovascular Psychiatry and Neurology · doi:10.1155/2009/475108 · Cited by 43
Mukherjee, S., Mukherjee, B., Mukhopadhyay, R., Naskar, K., Sundar, S., Dujardin, J., & Roy, S. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400710 · Cited by 41
The potential of biomarkers in psychiatry: focus on proteomics
Sokolowska, I., Wetie, A. G. N., Wormwood, K. L., Thome, J., Darie, C. C., & Woods, A. (2015) · Journal of neural transmission · doi:10.1007/s00702-013-1134-6 · Cited by 37
Impact of lithium alone and in combination with antidepressants on cytokine production in vitro
Petersein, C., Sack, U., Mergl, R., Schönherr, J., Schmidt, F. M., Lichtblau, N., Kirkby, K. C., Bauer, K., & Himmerich, H. (2014) · Journal of Neural Transmission · doi:10.1007/s00702-014-1328-6 · Cited by 41
Differences in cytokines between patients with generalised anxiety disorder and panic disorder
Zou, Z., Zhou, B., Huang, Y., Wang, J., Min, W., & Li, T. (2020) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2020.109975 · Cited by 41
Patova, O. A., Luanda, A., Михайлович, П. Н., Popov, S. V., Makangara, J. J., Kuznetsov, S. P., & Kalmykova, E. (2021) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2021.117946 · Cited by 38
Depressão, antidepressivos e sistema imune: um novo olhar sobre um velho problema
Vismari, L., Alves, G. J., & Palermo‐Neto, J. (2008) · Archives of Clinical Psychiatry (São Paulo) · doi:10.1590/s0101-60832008000500004 · Cited by 37
Xia, X. H., Pan, Y., Zhang, W., Cheng, G. S., & Kong, L. (2006) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.29.938 · Cited by 34
Andrade-Neto, V. V., Pereira, T. M., Canto‐Cavalheiro, M. M., & Torres-Santos, E. C. (2016) · Parasites & Vectors · doi:10.1186/s13071-016-1467-8 · Cited by 34
Nazimek, K., Kozlowski, M., Bryniarski, P., Strobel, S. D., Bryk, A. H., Myszka, M., Tyszka, A., Kuszmiersz, P., Nowakowski, J., & Filipczak-Bryniarska, I. (2016) · Experimental Biology and Medicine · doi:10.1177/1535370216643769 · Cited by 35
Protective Effects of Fluoxetine on Decompression Sickness in Mice
Blatteau, J.-É., Barre, S., Pascual, A. M., Castagna, O., Abraini, J. H., Risso, J., & Vallée, N. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049069 · Cited by 32
Başterzi, A. D., Yazıcı, K. U., Buturak, V., Çimen, B., Yazıcı, A., Eskandari, G., Acar, Ş. T., & Taşdelen, B. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.09.025 · Cited by 31
Zhang, X., Wang, Q., Wang, Y., Hu, J., Jiang, H., Cheng, W., Ma, Y., Liu, M., Sun, A., Zhang, X., et al. (2016) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2016.09.005 · Cited by 30
Somatic Drugs for Psychiatric Diseases: Aspirin or Simvastatin for Depression?
Rahola, J. G. (2012) · Current Neuropharmacology · doi:10.2174/157015912800604533 · Cited by 28
Salome, N., Tasiemski, A., Dutriez-Casteloot, I., Wigger, A., Landgraf, R., & Viltart, O. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2007.12.010 · Cited by 26
Singh, S., Dinesh, N., Kaur, P. K., & Shamiulla, B. (2014) · Parasitology Research · doi:10.1007/s00436-014-3868-y · Cited by 26
Lisitsyna, T. A., Veltishchev, D. Y., Lila, A. M., & Nasonov, E. L. (2019) · Rheumatology Science and Practice · doi:10.14412/1995-4484-2019-318-327 · Cited by 26
Denys, D. A. J. P., Fluitman, S. B. A. H. A., Kavelaars, A., Heijnen, C. J., & Westenberg, H. G. M. (2005) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2005.08.016 · Cited by 25
The neurodegenerative hypothesis of depression and the influence of antidepressant medications
Hall, S., Parr, B.-A., Hussey, S., Anoopkumar‐Dukie, S., Arora, D. S., & Grant, G. D. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176967 · Cited by 26
Guemei, A., Din, N. N. E., Baraka, A., & Darwish, I. E. S. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.141259 · Cited by 27
Hyperbaric oxygen in the treatment of acute retinal artery occlusion
Elder, M., Rawstron, J. A., & Davis, M. (2017) · Diving and Hyperbaric Medicine Journal · doi:10.28920/dhm47.4.233-238 · Cited by 22
In immune defense: redefining the role of the immune system in chronic disease
Rubinow, K. B., & Rubinow, D. R. (2017) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2017.19.1/drubinow · Cited by 22
Bosentan, a mixed endothelin receptor antagonist, induces antidepressant-like activity in mice
Pinho-Ribeiro, F. A., Borghi, S. M., Staurengo‐Ferrari, L., Filgueiras, G. B., Estanislau, C. R., & Verri, W. A., Jr. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.12.018 · Cited by 21
Immune Activation and Neuropsychiatric Symptoms in HIV Infection
Warriner, E. M., Rourke, S. B., Rourke, B. P., Rubenstein, S., Millikin, C., Buchanan, L., Connelly, P. W., Hyrcza, M. D., Ostrowski, M., Der, S., et al. (2010) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.22.3.321 · Cited by 20
Rachayon, M., Jirakran, K., Sodsai, P., Klinchanhom, S., Sughondhabirom, A., Plaimas, K., Suratanee, A., & Maes, M. H. J. (2022) · Pharmaceuticals · doi:10.3390/ph15040405 · Cited by 21
Self-citationHaastrup, E. K., Knorr, U., Erikstrup, C., Kessing, L. V., & Ullum, H. (2012) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2011.12.006 · Cited by 19
Brás, J. P., Pinto, S. F. T., Almeida, M. I., Prata, J., von Doellinger, O., Coelho, R. C., Barbosa, M. A., & Santos, S. G. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9554-7_28 · Cited by 19
Eslami, M., Monemi, M., Nazari, M. A., Azami, M. H., Rad, P. S., Oksenych, V., & Naderian, R. (2025) · Pharmaceuticals · doi:10.3390/ph18020197 · Cited by 18
Curzytek, K., Maes, M. H. J., & Kubera, M. (2021) · Neurotoxicity Research · doi:10.1007/s12640-021-00367-5 · Cited by 15
Self-citationThomas, J., Khanam, R., & Vohora, D. (2015) · Pharmacological Reports · doi:10.1016/j.pharep.2015.10.003 · Cited by 15
Probable fluoxetine-induced carotidynia
Jabre, M., Shahidi, G. A., & Bejjani, B.-P. W. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61694-9 · Cited by 14
Moughrabi, S. M., Evangelista, L. S., Habib, S., Kassabian, L., Breen, E. C., Nyamathi, A., & Irwin, M. R. (2013) · Biological Research For Nursing · doi:10.1177/1099800413496454 · Cited by 14
Meyer, M. F., Boor, M., Jansen, S., Pracht, E., Felsch, M., Klünter, H. D., Beutner, D., Grosheva, M., & Hüttenbrink, K. (2017) · Diving and Hyperbaric Medicine Journal · doi:10.28920/dhm47.4.216-222 · Cited by 12
Matt, S. M., Nolan, R., Manikandan, S., Agarwal, Y., Channer, B., Oteju, O., Daniali, M., Canagarajah, J., LuPone, T., Mompho, K., et al. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03403-9 · Cited by 14
Shukkoor, M. S. A., Baharuldin, M. T. H., Jais, A. M. M., Moklas, M. A. M., Fakurazi, S., & Basir, R. (2017) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2017/1469209 · Cited by 10
Hyperbaric oxygen-associated seizure leading to stroke
Warchol, J. M., Cooper, J. S., & Diesing, T. S. (2017) · Diving and Hyperbaric Medicine Journal · doi:10.28920/dhm47.4.260-262 · Cited by 9
Shamabadi, A., Karimi, H., Fallahzadeh, M. A., Vaseghi, S., Bahri, R. A., Fallahpour, B., Abdolghaffari, A. H., & Akhondzadeh, S. (2024) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000550 · Cited by 8
Patel, A. N., Varma, J. R., & Ganguly, B. (2024) · Cureus · doi:10.7759/cureus.62991 · Cited by 8
Matt, S. M. (2021) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2021.100353 · Cited by 8
Study on anti-inflammatory and immunomodulatory effects of fluoxetine in rat models of inflammation
Kostadinov, I., Delev, D. P., Petrova, A., Stanimirova, I., Draganova, K., Kružliak, P., Kostadinova, I. I., & Murdjeva, M. (2015) · European Journal of Inflammation · doi:10.1177/1721727x15618671 · Cited by 8
Potential Neuroimmunological Targets in the Treatment of Anxiety Disorders
Hou, R. H., Tang, Z., & Baldwin, D. S. (2013) · Modern trends in psychiatry · doi:10.1159/000351965 · Cited by 7
Affective temperament, depressive symptoms and interleukins in patients with psoriasis
Marek‐Józefowicz, L., Jaracz, M., & Borkowska, A. (2021) · Advances in Dermatology and Allergology · doi:10.5114/ada.2021.104289 · Cited by 7
RetractedEfeitos comportamentais e imunológicos da fluoxetina em ratos submetidos ao nado forçado
Fernandes, E. V., Ramos, S. D. P., Estanislau, C. R., & Venâncio, E. J. (2012) · Psicologia Teoria e Pesquisa · doi:10.1590/s0102-37722012000400008 · Cited by 6
Higher than normal plasma Iinterleukin-6 concentrations in brazilian patients with mood disorders
Miranda, H. C., Nunes, S. O. V., Reiche, E. M. V., Oda, J. M. M., & Watanabe, M. A. E. (2011) · Brazilian Archives of Biology and Technology · doi:10.1590/s1516-89132011000400010 · Cited by 6
Lost at sea: the medicine, physiology and psychology of prolonged immersion
Massey, H. C., Leach, J., Davis, M., & Vertongen, V. (2017) · Diving and Hyperbaric Medicine Journal · doi:10.28920/dhm47.4.239-247 · Cited by 6
Delayed hyperbaric intervention in life-threatening decompression illness
Perez, M. F., Perez, J. V. O., Serrano, A. R., Andal, M. P., & Aldover, M. C. (2017) · Diving and Hyperbaric Medicine Journal · doi:10.28920/dhm47.4.257-259 · Cited by 6
Sobieszczańska, A., Lis, M., Suszko-Pawłowska, A., & Szczypka, M. (2020) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.13251 · Cited by 6
Larenseweg 14, H., & Querido, A. L. (2017) · Diving and Hyperbaric Medicine Journal · doi:10.28920/dhm47.4.253-256 · Cited by 9
Neurological Disorders, Depression and Inflammation: Is there a Common Link?
Halaris, A. E. (2015) · Future Neurology · doi:10.2217/fnl.15.18 · Cited by 5
Gebhardt, S., Heiser, P., Fischer, S., Schneyer, T., Krieg, J.-C., & Vedder, H. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.07.002 · Cited by 5
Clementelli, C., Arita, Y., Ahmed, S., Pijush, D., Park, H. J., Levenson, A. S., & Peltier, M. R. (2021) · Placenta · doi:10.1016/j.placenta.2021.02.018 · Cited by 4
PO Box 494, S. T. 7., & Wijk, C. H. V. (2017) · Diving and Hyperbaric Medicine Journal · doi:10.28920/dhm47.4.248-252 · Cited by 4
Metadata
- Authors
- Kubera, M., Kenis, G., Bosmans, E., Kajta, M., Basta-Kaim, A., Scharpe, S., Budziszewska, B., & Maes, M.
- Affiliations
- Maj Institute of Pharmacology (PL)
- Vanderbilt University (US)
- Corresponding author
- Kubera, Marta
- Venue
- International Immunopharmacology
- Publisher
- Elsevier BV
- Published
- 2004-02
- Volume
- 4
- Issue
- 2
- Pages
- 185-192
- ISSN
- 1567-5769 (ISSN-L)
- OpenAlex
- W2040924241
- Cited by
- 126
- References
- 43
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 4 · 2022: 2 · 2021: 8 · 2020: 2 · 2019: 5 · 2017: 15 · 2016: 11 · 2015: 7 · 2014: 7 · 2013: 9 · 2012: 12
- FWCI
- 1.17
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- International Immunopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- antidepressants, interleukin-6, TNF-α, imipramine, venlafaxine, 5-hydroxytryptophan, fluoxetine, treatment-resistant depression, cytokine production, inflammation, cell-mediated immunity, phytohemagglutinin, lipopolysaccharide
- MeSH terms
- Venlafaxine Hydrochloride, Adult, Age Factors, Aging, Antidepressive Agents, Blood Cells, Cyclohexanols, Depressive Disorder, Drug Combinations, Female, Fluoxetine, Humans, 5-Hydroxytryptophan, Imipramine, Inflammation, Male, Middle Aged, Tumor Necrosis Factor-alpha, Interleukin-6, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review